vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Inspirato Inc (ISPO). Click either name above to swap in a different company.
Inspirato Inc is the larger business by last-quarter revenue ($55.5M vs $44.9M, roughly 1.2× AbCellera Biologics Inc.). Inspirato Inc runs the higher net margin — -8.1% vs -19.9%, a 11.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -19.6%). Inspirato Inc produced more free cash flow last quarter ($-3.0M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -11.4%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Inspirato Inc is a luxury travel and hospitality subscription service provider catering primarily to high-net-worth consumers across North America. It offers curated premium villa rentals, exclusive resort access, customized trip planning, and corporate travel incentive solutions for enterprise clients.
ABCL vs ISPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $55.5M |
| Net Profit | $-8.9M | $-4.5M |
| Gross Margin | — | 31.4% |
| Operating Margin | -63.7% | -8.0% |
| Net Margin | -19.9% | -8.1% |
| Revenue YoY | 788.4% | -19.6% |
| Net Profit YoY | 73.9% | -204.4% |
| EPS (diluted) | $-0.03 | $-0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | — | ||
| Q3 25 | $9.0M | $55.5M | ||
| Q2 25 | $17.1M | $63.1M | ||
| Q1 25 | $4.2M | $65.9M | ||
| Q4 24 | $5.0M | $63.1M | ||
| Q3 24 | $6.5M | $69.1M | ||
| Q2 24 | $7.3M | $67.4M | ||
| Q1 24 | $10.0M | $80.2M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $-4.5M | ||
| Q2 25 | $-34.7M | $-5.3M | ||
| Q1 25 | $-45.6M | $1.6M | ||
| Q4 24 | — | $-2.3M | ||
| Q3 24 | $-51.1M | $4.3M | ||
| Q2 24 | $-36.9M | $-8.7M | ||
| Q1 24 | $-40.6M | $1.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 31.4% | ||
| Q2 25 | — | 27.5% | ||
| Q1 25 | — | 38.8% | ||
| Q4 24 | — | 34.7% | ||
| Q3 24 | — | 71.5% | ||
| Q2 24 | — | 24.0% | ||
| Q1 24 | — | 39.5% |
| Q4 25 | -63.7% | — | ||
| Q3 25 | -851.8% | -8.0% | ||
| Q2 25 | -290.2% | -8.3% | ||
| Q1 25 | -1479.6% | 2.5% | ||
| Q4 24 | — | -3.2% | ||
| Q3 24 | -1439.4% | 9.8% | ||
| Q2 24 | -1276.2% | -22.8% | ||
| Q1 24 | -551.5% | 3.0% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | -8.1% | ||
| Q2 25 | -203.3% | -8.4% | ||
| Q1 25 | -1077.2% | 2.5% | ||
| Q4 24 | — | -3.6% | ||
| Q3 24 | -785.4% | 6.3% | ||
| Q2 24 | -504.3% | -12.9% | ||
| Q1 24 | -408.0% | 1.6% |
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.19 | $-0.36 | ||
| Q2 25 | $-0.12 | $-0.42 | ||
| Q1 25 | $-0.15 | $0.12 | ||
| Q4 24 | — | $0.98 | ||
| Q3 24 | $-0.17 | $0.62 | ||
| Q2 24 | $-0.13 | $-2.33 | ||
| Q1 24 | $-0.14 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $13.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $-134.0M |
| Total Assets | $1.4B | $228.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | $13.7M | ||
| Q2 25 | $92.4M | $16.7M | ||
| Q1 25 | $159.3M | $16.4M | ||
| Q4 24 | $156.3M | $21.8M | ||
| Q3 24 | $126.6M | $13.5M | ||
| Q2 24 | $148.3M | $18.8M | ||
| Q1 24 | $123.6M | $22.6M |
| Q4 25 | $966.9M | — | ||
| Q3 25 | $964.0M | $-134.0M | ||
| Q2 25 | $1.0B | $-129.7M | ||
| Q1 25 | $1.0B | $-125.2M | ||
| Q4 24 | $1.1B | $-129.9M | ||
| Q3 24 | $1.1B | $-134.6M | ||
| Q2 24 | $1.1B | $-35.2M | ||
| Q1 24 | $1.1B | $-27.5M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $228.3M | ||
| Q2 25 | $1.4B | $252.6M | ||
| Q1 25 | $1.3B | $270.1M | ||
| Q4 24 | $1.4B | $273.9M | ||
| Q3 24 | $1.4B | $273.3M | ||
| Q2 24 | $1.4B | $301.7M | ||
| Q1 24 | $1.5B | $313.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-2.2M |
| Free Cash FlowOCF − Capex | $-44.6M | $-3.0M |
| FCF MarginFCF / Revenue | -99.4% | -5.4% |
| Capex IntensityCapex / Revenue | 21.9% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-31.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | — | ||
| Q3 25 | $-52.6M | $-2.2M | ||
| Q2 25 | $-32.4M | $1.1M | ||
| Q1 25 | $-11.6M | $-6.6M | ||
| Q4 24 | $-108.6M | $-15.8M | ||
| Q3 24 | $-28.9M | $-13.7M | ||
| Q2 24 | $-30.0M | $-1.8M | ||
| Q1 24 | $-41.7M | $-7.2M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | $-3.0M | ||
| Q2 25 | $-45.8M | $468.0K | ||
| Q1 25 | $-22.2M | $-7.5M | ||
| Q4 24 | $-187.0M | $-21.2M | ||
| Q3 24 | $-47.4M | $-14.8M | ||
| Q2 24 | $-50.1M | $-3.7M | ||
| Q1 24 | $-65.8M | $-8.5M |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | -5.4% | ||
| Q2 25 | -267.9% | 0.7% | ||
| Q1 25 | -524.0% | -11.4% | ||
| Q4 24 | -3702.8% | -33.7% | ||
| Q3 24 | -728.4% | -21.5% | ||
| Q2 24 | -683.8% | -5.5% | ||
| Q1 24 | -661.5% | -10.6% |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | 1.4% | ||
| Q2 25 | 78.2% | 1.0% | ||
| Q1 25 | 251.1% | 1.3% | ||
| Q4 24 | 1552.7% | 8.7% | ||
| Q3 24 | 284.6% | 1.6% | ||
| Q2 24 | 274.6% | 2.8% | ||
| Q1 24 | 242.5% | 1.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -3.16× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -5.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
ISPO
| Residence And Hotel Travel | $25.9M | 47% |
| Subscription | $19.4M | 35% |
| Experiences And Bespoke Travel | $8.0M | 14% |
| Rewards And Other Revenue | $2.3M | 4% |
